PORTFOLIO COMPANIES
Chiesi Ventures invests in innovative biotech companies developing treatments for rare diseases.
4D MOLECULAR THERAPEUTICS

Mirum Pharmaceuticals is developing a compound, maralixibat, to treat Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), genetic liver disorders that affect primarily children.
MIRUM PHARMACEUTICALS
CURASEN
4D MOLECULAR THERAPEUTICS
VELOSBIO
VELOSBIO
AURA BIOSCIENCES
SENTIEN BIOTECH
KEZAR LIFE SCIENCES
GLYCOMINE
MINORYX THERAPEUTICS

Reneo Pharmaceuticals is a San Diego-based, private biotechnology company focused on the identification and development of novel treatments for orphan diseases.
RENEO